A Multi-Center, Open-Label Study to Evaluate the Long-term Safety of Weekly Intravenous Infusions of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency
Latest Information Update: 02 Dec 2022
At a glance
- Drugs Alpha 1-antitrypsin (Primary)
- Indications Alpha 1-antitrypsin deficiency
- Focus Adverse reactions; Therapeutic Use
- Sponsors Grifols
- 14 Jun 2021 Status changed from active, no longer recruiting to completed.
- 08 Feb 2019 Planned End Date changed from 15 Mar 2020 to 20 Jan 2023.
- 08 Feb 2019 Planned primary completion date changed from 15 Mar 2020 to 20 Jan 2023.